Skip to main content
Log in

Leukotriene (LT) receptor antagonists. Heterocycle-linked tetrazoles and carboxylic acids. LY203647

  • Design and Development of Drugs
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

LY171883, 1-[2-hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)butoxy]phenyl] ethanone, is an orally active antagonist of LTD4- and LTE4-induced responses in a variety of test systems. We prepared a new series of LT antagonists based on a proposed model of LY171883 binding to the LTE4 receptor in which then-propyl and tetrazole moieties of LY171883 occupy those parts of the receptor to which the C1-C5 chain and the cysteinyl carboxyl of LTE4 bind, respectively. The new compounds have an acidic function corresponding to the glycine carboxyl of LTD4 linked through a heterocyclic group which is proposed to bind to the LTD4 receptor where the cysteinyl glycine amide bond of LTD4 binds. LY203647, 1-[2-hydroxy-3-propyl-4-[4-[2-[4-(1H-tetrazol-5-yl) butyl]-2H-tetrazol-5-yl]butoxy]phenyl] ethanone, showed good LTD4 antagonist activity with a suitable pharmacologic and toxicologic profile and has been chosen for clinical evaluation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. J. H. Fleisch, L. E. Rinkema, C. A. Whitesitt and W. S. Marshall,Development of cysteinyl leukotriene receptor antagonist. InAdvances in Inflammation Research. (Eds. A. Lewis et al.) pp. 173–189, Raven Press, New York 1988.

    Google Scholar 

  2. L. E. Rinkema, C. R. Roman and J. H. Fleisch,Pharmacologic analysis of LY171883 as a leukotriene E 4 (LTE 4)receptor antagonist. Fed. Proc.46, 1461 (1987).

    Google Scholar 

  3. S. A. Silbaugh, P. W. Stengel, P. A. Pechous and W. S. Marshall,Reversal of LTD 4-and LTE 4-induced airway constriction in the guinea pig. Am. Rev. Resp. Dis.137, 374 (1988).

    Google Scholar 

  4. W. S. Marshall, T. Goodson, G. J. Cullinan, D. Swanson-Bean, K. D. Haisch, L. E. Rinkema and J. H. Fleisch,Leukotriene receptor antagonists. 1. Synthesis and structure-activity relationships of alkoxyacetophenone derivatives. J. Med. Chem.30, 682–689 (1987).

    Google Scholar 

  5. J. M. Van Rossum,Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch. Int. Pharmacodyn. Ther.143, 229–330 (1963).

    Google Scholar 

  6. R. F. Furchgott,The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. InHandbook of Experimental Pharmacology, vol. 33. (Eds. O. Eichler, A. Farah, H. Herken and A. D. Welch) pp. 283–335, Springer, New York 1972.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marshall, W.S., Sigmund, S.K., Whitesitt, C.A. et al. Leukotriene (LT) receptor antagonists. Heterocycle-linked tetrazoles and carboxylic acids. LY203647. Agents and Actions 27, 309–312 (1989). https://doi.org/10.1007/BF01972807

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01972807

Keywords

Navigation